Affinity Asset Advisors »

Radiopharm Theranostics shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Radiopharm Theranostics (RADX) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Radiopharm Theranostics

Tip: Access up to 7 years of quarterly data

All positions including Radiopharm Theranostics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Radiopharm Theranostics by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $166k 36k 4.66
2025-03-31 $311k 65k 4.81
2024-12-31 $684k 156k 4.38

More positions owned by Affinity Asset Advisors

Insmed Com Par $.01 (INSM)
Verona Pharma Sponsored Ads (VRNA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Merus N V (MRUS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Lexeo Therapeutics (LXEO)

View all positions for Affinity Asset Advisors

Top funds holding Radiopharm Theranostics

Silverarc Capital Management
Vgi Partners Pty
UBS Group
Pnc Financial Services

View all funds holding Radiopharm Theranostics